Topical skin formulations
US12161891B2 · kind B2 · utility
0Cited by
13References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2024 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Jan 19, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/59
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating skin is disclosed. The method can include topically applying to a person's skin a composition comprising 0.0001% to 5% w/w of a hydrolyzed algae extract comprising exopolysaccharides from Halymenia durvillei, and 0.0001% to 5% w/w of a saccharide isomerate comprising an exopolysaccharide synthesized by Vibrio alginolyticus, wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.